Live Breaking News & Updates on Pneumococcal Diseases

Stay updated with breaking news from Pneumococcal diseases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Merck's adult-specific pneumococcal vaccine shows promise in late-stage study

Merck's adult-specific pneumococcal vaccine shows promise in late-stage study
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Eliav Barr , Meeting Of The International Society Pneumonia , Merck Co , Merck Research Laboratories , European Society Of Clinical Microbiology , World Health Organization , World Health , European Society , Clinical Microbiology , Infectious Diseases , International Society , Pneumococcal Diseases ,

Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults

Late-breaker Phase 3 STRIDE-10 trial presented as an oral presentation at European Society of Clinical Microbiology and Infectious Diseases

Results build on the data supporting the clinical profile. ....

United States , Comunidad Autonoma De Cataluna , Eliav Barr , Walter Orenstein , Emory University , Meeting Of The International Society Pneumonia , Statement Of Merck Co Inc , European Medicines Agency , World Vaccine Congress West Coast , Exchange Commission , Merck Research Laboratories , Merck Scientific Advisory Committee , Us Centers For Disease , European Society Of Clinical Microbiology , Merck Co Inc , Drug Administration , European Society , Clinical Microbiology , Infectious Diseases , International Society , Pneumococcal Diseases , Vaccine Congress West , Scientific Advisory , Merck Research , Prescription Drug User Fee Act , Disease Control ,

Merck (MRK) Q1 2024 Earnings Call Transcript

MRK earnings call for the period ending March 31, 2024. ....

United States , Luisa Hector Berenberg , Daiichi Sankyo Adcs , Seamus Fernandez , Asia Pacific , James Shin , Louise Chen , Louise Chen Cantor Fitzgerald , Evan Seigerman , Peter Dannenbaum , Rob Davis , Daina Graybosch Leerink , Chris Schott Jpmorgan , Tim Anderson , Carter Gould Barclays , Luisa Hector , Chris Shibutani Goldman Sachs , Terence Flynn , Terence Flynn Morgan Stanley , Seamus Fernandez Guggenheim , Chris Schott , Daiichi Sankyo , Caroline Litchfield , Evan Siegerman , Carter Gould , Chris Shibutani ,

Merck (MRK) Q1 2024 Earnings Call Transcript

MRK earnings call for the period ending March 31, 2024. ....

United States , Chris Schott , Seamus Fernandez , James Shin , Carter Gould , Seamus Fernandez Guggenheim , Terence Flynn Morgan Stanley , Daina Graybosch , Chris Shibutani Goldman Sachs , Chris Schott Jpmorgan , Terence Flynn , Caroline Litchfield , Luisa Hector , Carter Gould Barclays , Rob Davis , Trung Huynh , Louise Chen Cantor Fitzgerald , Daiichi Sankyo Adcs , Evan Seigerman , Evan Siegerman , Tim Anderson , Peter Dannenbaum , Asia Pacific , Daina Graybosch Leerink , Daiichi Sankyo , Luisa Hector Berenberg ,

Merck's V116 Vaccine Shows Promising Results in Phase 3 Studies at ISPPD: Key Findings and Real-World Impact

Merck's V116, a 21-valent pneumococcal vaccine, exhibits strong immunogenicity and coverage in diverse adult populations. Real-world data reveal its potential to combat pneumococcal diseases effectively.
....

South Africa , Cape Town , Western Cape , Heather Platt , Merck Heather Platt , Meeting Of The International Society Pneumonia , Global Clinical Development For Vaccines , Infection Intel , Staying Ahead , Infection Control , International Society , Pneumococcal Diseases , Prescription Drug User Fee Act , Pneumococcal Pneumonia Epidemiology , Urine Serotyping , Mental Outcomes , Global Clinical Development , Merck V116 ,